Reuters logo
BRIEF-Anhui Anke Biotechnology Group unit gets CEP for drug OXYTOCIN from EDQM
April 20, 2017 / 3:37 AM / in 6 months

BRIEF-Anhui Anke Biotechnology Group unit gets CEP for drug OXYTOCIN from EDQM

April 20 (Reuters) - Anhui Anke Biotechnology Group Co Ltd :

* Says its wholly owned subsidiary Shanghai SOHO-YIMING Pharmaceuticals Co Ltd got Certificate of Suitability to Monograph of European Pharmacopoeia (CEP) for the drug oxytocin API(OXYTOCIN) from European Directorate for Quality of Medicines & HealthCare (EDOM)

* Oxytocin API(OXYTOCIN) is used for treatment of uterine bleeding after induction of labor

Source text in Chinese: goo.gl/AGujBF

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below